Modern Radiation Therapy and Hormone Therapy for Localised Prostate Cancer
This article discusses the importance of referral of patients with prostate cancer for consideration of radiation therapy if active treatment is considered.
Written by A/Prof Sandra Turner MBBS FRANZCR and Dr Lucinda Morris BA MBBS FRANZCR
A/Prof Turner is a radiation oncologist in Sydney with over 20 years experience in the treatment of urological cancers, in particular prostate cancer. She is involved with prostate cancer research through the TransTasman Radiation Oncology Group. She is on the Faculty of Radiation Oncology Council of RANZCR, and is the Clinical Lead on the Targeting Cancer advocacy campaign raising awareness of the effectiveness of Radiation Therapy in cancer care.
Dr Lucinda Morris is a radiation oncology fellow based at the Crown Princess Mary Cancer Centre. She currently chairs the RANZCR Targeting Cancer Working and Advisory Group and a key focus of her research and advocacy is on raising community and general practitioner awareness of the benefits of radiation therapy in cancer care.